Delayed gastrointestinal transit in patients with hepatocellular carcinoma

Abstract

Abstract Background and Aim: Disturbed gastrointestinal (GI) motility exists in cirrhotic patients; however, less is known about the character of GI transit in hepatocellular carcinoma (HCC) patients. It is interesting to study the GI transit in HCC patients and to explore the patient factors modulating GI transit. Methods: A non‐invasive hydrogen breath test, which measured the orocecal transit time (OCTT), was used to study GI transit in 40 HCC patients, 20 cirrhotics and 40 age‐ and sex‐matched healthy volunteers with normal bowel habits. Meanwhile, their clinical manifestations and various blood parameters, such as platelet count, prothrombin time, erythrocyte sedimentation rate etc. were collected. The plasma endothelin‐1 and nitrate/nitrite levels were also measured. Results: The OCTT were delayed in HCC and cirrhotic patients compared with controls (116.3 ± 7.8 and 104.5 ± 10.6 vs 75.3 ± 5.1 min, P < 0.05). Neither the severity of liver damage, presence of ascites, tumor size, portal hypertension, nor various blood parameters, such as nitrate/nitrite, endothelin‐1, platelet count etc., had any influence on GI transit. Only serum α‐fetoprotein levels exhibited a trend toward positive correlation with the OCTT ( r = 0.271, P = 0.091). Conclusions: Hepatocellular carcinoma patients have delayed GI transit. The confounding factor responsible for the disturbance of GI transit in HCC patients needs further exploration. © 2002 Blackwell Publishing Asia Pty Ltd

Keywords

Affiliated Institutions

• National Yang Ming Chiao Tung University TW
• Taipei Veterans General Hospital TW

Related Publications